Table 1. Patient characteristics.
Variable | of 224 | Fraction (%) | |
Gender | Male / Female | 196 / 28 | 87.5 / 12.5 |
Tumor localization | Oral cavity / Oropharynx | 51 / 88 | 22.8 / 39.3 |
Hypopharynx, Supraglottic larynx | 70 / 15 | 31.2 / 6.7 | |
cT stage | 1 / 2 | 8 / 29 | 3.6 / 12.9 |
3 / 4 / Missing | 32 / 154 / 1 | 14.3 / 68.8 / 0.4 | |
cN stage | 0 / 1 | 18 / 11 | 8.0 / 4.9 |
2 / 3 | 164 / 30 | 73.2 / 13.4 | |
Missing | 1 | 0.5 | |
Grade | 1 / 2 | 6 / 145 | 2.7 / 64.7 |
3 / 4 | 64 / 2 | 28.6 / 0.9 | |
Missing | 7 | 3.1 | |
WHO | 0 / 1 | 17 / 181 | 7.6 / 80.8 |
2 / 3 | 21 / 5 | 9.4 / 2.2 | |
Smoking | Never / Yes | 17 / 170 | 7.6 / 75.9 |
Stopped / Missing | 29 / 8 | 12.9 / 3.6 | |
Chemotherapy | Yes | 123 | 54.9 |
No | 101 | 45.1 | |
p53 | Negative | 108 | 48.2 |
Positive | 113 | 50.5 | |
Missing | 3 | 1.3 | |
p16 | Negative | 180 | 80.3 |
Positive | 38 | 17.0 | |
Missing | 6 | 2.7 | |
Variable | Median (Range) | ||
Age | 58.5 (35.3–91.8) | ||
Delivered dose (Gy) | 70.6 (68.0–77.6) | ||
Treatment time (days) | 40.5 (36.0–58.0) |
Abbreviations: WHO, World Health organization